Physician profile
Katy Cox
NPI 1841636263
$2,618.36
in general payments reported to CMS, 2019-2025
22 companies · $22.59 in 2025
The $22.59 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,865 · 2020: $484 · 2021: $62.77 · 2022: $159 · 2023: $25.00 · 2025: $22.59.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $25.00 · Food and Beverage: $22.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $25.00 |
| Food and Beverage | $22.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,500.00 | 2019 | |
| Abbvie INC. | $333.44 | 2019-2022 | |
| Pfizer INC. | $94.49 | 2019-2021 | |
| Allergan, INC. | $88.33 | 2019-2020 | |
| Hologic Sales and Service, LLC | $79.64 | 2019-2020 | |
| Therapeuticsmd, INC. | $61.05 | 2019-2020 | |
| Mylan Pharmaceuticals INC. | $56.21 | 2020 | |
| Merck Sharp & Dohme LLC | $52.92 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $45.94 | 2019-2020 | |
| Avion Pharmaceuticals | $45.45 | 2020-2021 | |
| Duchesnay USA Incorporated | $41.43 | 2019 | |
| Amgen INC. | $32.70 | 2019-2021 | |
| Amag Pharmaceuticals, INC. | $30.37 | 2019 | |
| Coopersurgical, INC. | $25.00 | 2023 | Summit Doppler |
| Organon LLC | $22.59 | 2025 | Nexplanon |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $17.64 | 2020 | |
| Ethicon US, LLC | $16.65 | 2020 | |
| Davol INC. | $16.18 | 2020 | |
| Baudax Bio INC. | $15.89 | 2020 | |
| Eisai INC. | $15.79 | 2020 | |
| Sage Therapeutics, LLC | $13.72 | 2020 | |
| Exeltis, USA INC. | $12.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katy Cox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.